title: Immunological and neurotrophic markers of risk status and illness development in high-risk youth: understanding the neurobiological underpinnings of bipolar disorder.
abstract: Bipolar disorder is a highly heritable illness that onsets in adolescence and young adulthood. We examined gene expression (mRNA) and protein levels of candidate immune and neurotrophic markers in well-characterized offspring of bipolar parents in order to identify reliable indicators of illness risk status and the early clinical stages of illness development. We measured mRNA expression and protein levels in candidate immune (TNF-α, IL-1β, IL-10, IFN-δ) and neurotrophic (brain-derived neurotrophic factor (BDNF)) markers from plasma. High-risk offspring were identified from families in which one parent had confirmed bipolar disorder. Control offspring were identified from families in which neither parent met lifetime criteria for a major psychiatric disorder. All parental Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnoses were based on Schedule for Affective Disorders - Lifetime Version (SADS-L) interviews and blind consensus review. As part of an ongoing study, all offspring were prospectively assessed using KSADS-PL format interviews and diagnoses confirmed on blind consensus review. High-risk offspring had significantly increased IL-6 (p = 0.050) and BDNF (p = 0.006) protein levels compared to controls. Those high-risk offspring in earlier compared to later clinical stages of illness development had higher IL-6 (p = 0.050) and BDNF (p = 0.045) protein levels. After adjustments, only differences in BDNF protein levels remained significant. There was a moderating effect of the BDNF genotype on both gene expression and protein levels in high-risk compared to control offspring. The BDNF genotype also moderated the association between clinical stage and gene expression levels in high-risk offspring. These findings provide support for detectable differences in candidate immune and neurotrophic markers in individuals at high risk of developing bipolar disorder and for detectable changes over the clinical stages of illness development. These associations appear to be moderated by genetic variants.
authors.affiliation: Department of Psychiatry and Hotchkiss Brain Institute (HBI), University of Calgary, TRW Building, 3280 Hospital Drive, NW, Room 4D6, Calgary, AB, T2N 4Z6, Canada, acduffy@ucalgary.ca.
authors.forename: Anne
authors.initials: A
authors.lastname: Duffy
authors.forename: Julie
authors.initials: J
authors.lastname: Horrocks
authors.forename: Sarah
authors.initials: S
authors.lastname: Doucette
authors.forename: Charles
authors.initials: C
authors.lastname: Keown-Stoneman
authors.forename: Paul
authors.initials: P
authors.lastname: Grof
authors.forename: Ana
authors.initials: A
authors.lastname: Andreazza
authors.forename: L Trevor
authors.initials: LT
authors.lastname: Young